8-23706325-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136271.3(NKX2-6):c.274C>A(p.Gln92Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,530,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q92Q) has been classified as Likely benign.
Frequency
Consequence
NM_001136271.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NKX2-6 | NM_001136271.3 | c.274C>A | p.Gln92Lys | missense_variant, splice_region_variant | 1/2 | ENST00000325017.4 | |
LOC107986930 | XR_001745842.2 | n.1312+37575G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NKX2-6 | ENST00000325017.4 | c.274C>A | p.Gln92Lys | missense_variant, splice_region_variant | 1/2 | 2 | NM_001136271.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000201 AC: 3AN: 149418Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000723 AC: 11AN: 152218Hom.: 0 AF XY: 0.0000497 AC XY: 4AN XY: 80562
GnomAD4 exome AF: 0.0000152 AC: 21AN: 1381222Hom.: 0 Cov.: 35 AF XY: 0.0000133 AC XY: 9AN XY: 678288
GnomAD4 genome ? AF: 0.0000134 AC: 2AN: 149532Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72780
ClinVar
Submissions by phenotype
Conotruncal heart malformations Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 423840). This variant has not been reported in the literature in individuals affected with NKX2-6-related conditions. This variant is present in population databases (rs530501230, gnomAD 0.05%). This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 92 of the NKX2-6 protein (p.Gln92Lys). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2017 | The Q92K variant in the NKX2-6 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The Q92K variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The Q92K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret Q92K as a variant of uncertain significance - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at